## Core Concept
The killed poliovirus vaccine (KPV) or inactivated poliovirus vaccine (IPV) is a vaccine used to prevent poliomyelitis. It is made from inactivated (killed) poliovirus strains. Understanding the characteristics of IPV is crucial for public health and vaccination strategies.

## Why the Correct Answer is Right
The correct answer relates to the specific features of the killed poliovirus vaccine. IPV provides immunity by inducing humoral immunity (antibodies) but does not provide mucosal immunity as effectively as the live attenuated oral poliovirus vaccine (OPV). IPV is administered via injection and is known for its safety profile, particularly in immunocompromised individuals.

## Why Each Wrong Option is Incorrect
- **Option A:** Typically, IPV does not require stringent cold chain conditions compared to OPV but still needs to be refrigerated. If an option suggests IPV has a very short shelf life or requires a very strict cold chain that is more aligned with OPV, it could be incorrect.
- **Option B:** If an option mentions that IPV provides long-term immunity, this is generally correct. IPV induces a strong antibody response that provides long-term protection against poliomyelitis.
- **Option C:** If an option states that IPV can be given to immunocompromised individuals, this is correct. IPV is safe for use in immunocompromised individuals because it contains inactivated virus.
- **Option D:** Without specific details on the options, a common incorrect statement could be that IPV provides mucosal immunity similar to OPV. IPV primarily induces systemic immunity and is less effective at inducing mucosal immunity compared to OPV.

## Clinical Pearl / High-Yield Fact
A key point to remember is that IPV is particularly recommended for individuals who cannot receive live vaccines, such as those with weakened immune systems. Additionally, the switch from OPV to IPV in some countries is driven by the goal to eliminate vaccine-derived poliovirus cases.

## Correct Answer: D. Provides mucosal immunity.